Short answer
Quantinuum Inc (QNT) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 2.02 (Results of Operations and Financial Condition). Quantinuum announced financial results for the quarter ended June 30, 2026.
Quantinuum Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Quantinuum announced financial results for the quarter ended June 30, 2026
- Investors should review Exhibit 99.1 for revenue, earnings, guidance and operating developments
Item 7.01 · Regulation FD Disclosure
- Multi-year strategic partnership with Oracle to accelerate hybrid quantum computing adoption
- Oracle Cloud Infrastructure integration, expanding Quantinuum’s potential enterprise distribution
- Strategic relevance: increased cloud access for quantum workloads and possible commercial adoption catalyst
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $8.0M, up 279% year over year, signaling accelerating commercial traction from a very small base
- GAAP net loss $597M, including $465M equity compensation and $48M warrant remeasurement, obscuring underlying operating performance
- Adjusted EBITDA loss $68M, wider than $43M, while adjusted gross margin remained 62%
- IPO raised $1.7B gross, lifting cash and short-term investments to $2.1B and providing substantial funding for R&D and expansion
- FY2026 revenue guidance established at $28M to $32M, with Oracle OCI and HPE partnerships supporting enterprise adoption перспեկտիվ
Item EX-99.2 · Exhibit EX-99.2
- Multi-year Oracle partnership, placing Quantinuum’s Helios quantum computer inside a US-based OCI AI data center
- Planned OCI quantum service expands enterprise access without customer-owned quantum hardware or specialized facilities
- Helios offers 98 physical qubits and 99.921% average two-qubit gate fidelity, supporting hybrid quantum-AI and HPC workloads
- Target applications include drug discovery, materials science, financial modeling, logistics, energy, and optimization
- Commercial impact remains execution-dependent, with OCI service preview planned in the coming months and no financial terms disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quantinuum Inc 8-K filings
Get the next QNT 8-K as it lands
Follow QNT for push alerts, or ask the research agent what this filing means.